These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27207860)

  • 1. Atypical neuroleptic malignant syndrome in a young male precipitated by oral sodium valproate.
    Menon V; Rajkumar RP; Thamizh JS; Selvakumar N
    Aust N Z J Psychiatry; 2016 Dec; 50(12):1208-1209. PubMed ID: 27207860
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic effects of nefazodone.
    Brazelton T; Blanc PD; Olson KR
    Ann Emerg Med; 1997 Oct; 30(4):550-1. PubMed ID: 9326873
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome following levomepromazine discontinuation.
    Tanii H; Saka K; Inoue K; Okada M
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
    Crosby D; Peterson J; Carroll BT
    Ann Clin Psychiatry; 2013 Feb; 25(1):69-70. PubMed ID: 23376873
    [No Abstract]   [Full Text] [Related]  

  • 5. Valproate and polycystic ovaries.
    Irwin M; Masand P
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):9-10. PubMed ID: 9444888
    [No Abstract]   [Full Text] [Related]  

  • 6. DRESS syndrome: Addressing the drug hypersensitivity syndrome on combination of Sodium Valproate and Olanzapine.
    Penchilaiya V; Kuppili PP; Preeti K; Bharadwaj B
    Asian J Psychiatr; 2017 Aug; 28():175-176. PubMed ID: 28784381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inappropriate antidiuretic hormone secretion induced by sodium valproate].
    Bève E; Beck E; Pinto E; Ansseau M
    Rev Med Liege; 2010 Jan; 65(1):6-9. PubMed ID: 20222501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inadequate vasopressin secretion and valproate].
    Franco Hidalgo S; Prieto de Paula JM; Salado Valdivieso I
    Endocrinol Nutr; 2009 May; 56(5):277. PubMed ID: 19627751
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 10. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 11. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
    Young L; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
    [No Abstract]   [Full Text] [Related]  

  • 12. Fulminant hepatic failure in the context of reinstituting valproate use.
    Rej S; Chen T; Edwards M; Zicherman V
    Psychosomatics; 2014; 55(3):303-4. PubMed ID: 24360531
    [No Abstract]   [Full Text] [Related]  

  • 13. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
    Normann C; Brandt C; Berger M; Walden J
    Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-induced tinnitus misinterpreted as psychotic symptoms.
    Reeves RR; Mustain DW; Pendarvis JE
    South Med J; 2000 Oct; 93(10):1030-1. PubMed ID: 11147471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential risks associated with high-dose valproate in pregnancy in psychiatric patients.
    Vajda FJ; Solinas C
    Aust N Z J Psychiatry; 2005 Jun; 39(6):526-7. PubMed ID: 15943661
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproic acid-induced eosinophilic pleural effusion in a patient with pediatric bipolar disorder.
    Aral A; Usta MB; Karabekiroglu K
    Asia Pac Psychiatry; 2017 Sep; 9(3):. PubMed ID: 28856844
    [No Abstract]   [Full Text] [Related]  

  • 17. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].
    Rottach KG; Weiss-Brummer J; Wieland U; Schmauss M
    Nervenarzt; 2000 May; 71(5):401-3. PubMed ID: 10846716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal effects of valproic acid?
    Garland EJ; Behr R
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1424-5. PubMed ID: 8936907
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-Dose Valproate-Related Peripheral Edema in Patients With Bipolar Disorder: Two Case Reports.
    Maneerot T; Jenraumjit R; Kijsawatpaiboon S; Reungyos J
    J Clin Psychopharmacol; 2019; 39(4):412-413. PubMed ID: 31188235
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines.
    Vasudev K; Mead A
    Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.